Table 1 Characteristics of the ILD physicians who participated in the nominal groups on barriers to antigen identification and avoidance in CHP
Participant characteristics | Distribution (n = 25) |
|---|---|
Years caring for CHP Patients | |
 0–5 | 4 |
 6–10 | 6 |
 11–15 | 1 |
 16–20 | 8 |
 20+ | 6 |
Percentage of CHP patients in the provider’s practice | 14.3% (3–35%) |
US Region of Practice [21] | |
 Northeastern United States | 7 |
 Southeastern United States | 8 |
 Midwestern United States | 8 |
 Southwestern United States | 1 |
 Western United States | 1 |
Session Participation (# of participants) | |
 Session 1 | 6 |
 Session 2 | 10 |
 Session 3 | 9 |